RFQ For NDC00469 2033 25 NSN part by Astellas Pharma Us Inc with NSN 6505011054093
Heparin Sodium Inje
NDC00469 2033 25 procurement notes
Thank you for having an interest in part number NDC00469 2033 25, an item from Astellas Pharma Us Inc (CAGE Code 10001) that is listed with the description - Support. Be sure to review the details provided on this page, and should you wish to move forward with procurement, fill out and submit the Request for Quote (RFQ) form provided below at your earliest convenience.
If you also require other items from FSC or wish to speak with staff directly, do not hesitate to give us a call or email at any time. We are ready to support you with competitive options for part number NDC00469 2033 25and other items of interest, so be sure to get in touch today!
Reference data
Sourcing more than one part?
Upload a bill of materials (BOM) or paste a list of part numbers — every line bundles into a single RFQ. No checkout, no payment.
- AS9120:2025· Aerospace QMS
- ISO 9001:2015· Quality Management
- FAA AC 00-56B· Voluntary Industry Distributor Accreditation
- U.S. ONLY· Fulfillment
Characteristics Data of NSN 6505-01-105-4093, 6505011054093
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1000.000 UNITS HEPARIN SODIUM PER MILLILITER |
| AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 30.000 MILLILITERS |
| CRMW | RAW MATERIAL SOURCE | PORCINE INTESTINAL MUCOSA |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| CSGS | ADMINISTRATION | INTRAVENOUS OR SUBCUTANEOUS |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |